AI Article Synopsis

  • The FDA requires marketing authorization for products to include clinical data that reflects the US patient population, emphasizing the need for ethnically diverse foreign clinical data conducted under Good Clinical Practices.
  • The recent Omnibus Legislation gives the FDA the power to mandate Diversity Plans for Phase 3 clinical trials, aiming to improve participation from underrepresented racial and ethnic groups.
  • A guidance document issued by the FDA outlines expectations for sponsors on foreign clinical data and enrollment strategies for diverse populations in clinical trials, with an update anticipated in 2023.

Article Abstract

The Food and Drug Administration (FDA) has an expectation that products filed for marketing authorization have to include data that are representative of the US patient population. Any foreign clinical data that is submitted has to represent an ethnically diverse population that is generated utilizing qualified Principal Investigators (PIs) and conducted according to Good Clinical Practices (GCP) requirements outlined in 21 CFR 312.120, Foreign clinical studies not conducted under an IND. With the recent passing of the Omnibus Legislation, FDA now also has the authority to require Diversity Plans for all Phase 3 clinical trials of new drugs or "as appropriate, another pivotal study of a new drug." The FDA has released a guidance document, "Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials" (April 2022), for the industry with expectations to update the document in 2023 now that legislation is passed. This whitepaper discusses the FDA guidance and expectations of sponsors with regards to foreign clinical data and the intersection with enrolling ethnically diverse populations in clinical studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417185PMC
http://dx.doi.org/10.1016/j.conctc.2024.101331DOI Listing

Publication Analysis

Top Keywords

foreign clinical
12
clinical
8
clinical data
8
ethnically diverse
8
clinical studies
8
populations clinical
8
regulatory landscape
4
landscape patient
4
patient requirements
4
requirements clinical
4

Similar Publications

Effects of Chemical Pretreatments of Wood Cellulose Nanofibrils on Protein Adsorption and Biological Outcomes.

ACS Appl Mater Interfaces

January 2025

Center of Translational Oral Research (TOR), Department of Clinical Dentistry, University of Bergen, Bergen 5009, Norway.

Wood-based nanocellulose is emerging as a promising nanomaterial in the field of tissue engineering due to its unique properties and versatile applications. Previously, we used TEMPO-mediated oxidation (TO) and carboxymethylation (CM) as chemical pretreatments prior to mechanical fibrillation of wood-based cellulose nanofibrils (CNFs) to produce scaffolds with different surface chemistries. The aim of the current study was to evaluate the effects of these chemical pretreatments on serum protein adsorption on 2D and 3D configurations of TO-CNF and CM-CNF and then to investigate their effects on cell adhesion, spreading, inflammatory mediator production , and the development of foreign body reaction (FBR) .

View Article and Find Full Text PDF

Evidence-Based Practice Attitudes of Neonatal Nurses: A Multicenter Study on the Examination of Internal and External Factors.

J Perinat Neonatal Nurs

January 2025

Author Affiliations: Department of Children Health and Disease Nursing, Nursing Faculty, Selçuk University, Konya, Türkiye (Drs Taş Arslan and Küçükoğlu); Department of Medical Services and Techniques, First and Emergency Aid Program, Vocational School of Health Services, Kırsehir Ahi Evran University, Kırsehir, Türkiye (Ms Tar Bolacalı); Department of Medical Services and Techniques, Dialysis Program, Vocational High School, Lokman Hekim University, Ankara, Türkiye (Ms Tanrıkulu); and Neonatal Intensive Care Unit, Konya City Hospital, Konya, Turkey (Ms Ertürk).

Objective: This study aims to determine the internal and external factors affecting the attitudes of neonatal intensive care nurses toward evidence-based practices (EBP).

Methods: The population of this descriptive, cross-sectional, and relation-seeking multicenter study consisted of nurses working in 5 neonatal intensive care units located in 3 provinces of Türkiye. Data were collected using the Information Form, which included nurses' sociodemographic information and internal-external factors affecting evidence-based care practices, the Evidence-Based Nursing Attitude Questionnaire (EBNAQ).

View Article and Find Full Text PDF

Purpose: To analyze the clinical data of five patients involving intravesical magnetic beads, summarizing diagnostic and therapeutic experiences.

Methods: From January 2018 to November 2023, five pediatric patients were treated for intravesical magnetic beads at Shenzhen Children's Hospital. We retrospectively reviewed and analyzed the records of these patients, including demographic characteristics, clinical symptoms, imaging studies, and treatment methods.

View Article and Find Full Text PDF

Background: Managing foreign bodies in otorhinolaryngology requires appropriate treatment based on case severity.

Objective: To analyze the clinical characteristics associated with complicated cases of foreign bodies.

Methods: This study categorized patients with diagnosed foreign bodies into complicated and uncomplicated cases.

View Article and Find Full Text PDF

Chest imaging in children presents unique challenges due to varying requirements across age groups. For chest radiographs, achieving optimal images often involves careful positioning and immobilisation techniques. Antero-posterior projections are easier to obtain in younger children, while lateral decubitus radiographs are sometimes used when expiratory images are difficult to obtain and for free air exclusion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!